Pharmaceutical formulation with nonsteroidal antiphlogistic agents and nucleic acids for the internalization of nucleic acids into eucaryotic cells

Details for Australian Patent Application No. 2003260278 (hide)

Owner Avontec GmbH

Inventors Wagner, Andreas H.; Hecker, Markus

Agent Wrays

Pub. Number AU-B-2003260278

PCT Number PCT/DE03/02901

PCT Pub. Number WO2004/022102

Priority 102 40 418.6 02.09.02 DE

Filing date 2 September 2003

Wipo publication date 29 March 2004

Acceptance publication date 5 June 2008

International Classifications

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61K 31/192 (2006.01)

A61K 31/4035 (2006.01)

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61K 31/711 (2006.01) - Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links

A61K 47/02 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Inorganic compounds

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 29/02 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C12N 15/87 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation

Event Publications

20 November 2003 Complete Application Filed

  Priority application(s): 102 40 418.6 02.09.02 DE

13 May 2004 Application Open to Public Inspection

  Published as AU-B-2003260278

5 June 2008 Application Accepted

  Published as AU-B-2003260278

2 October 2008 Standard Patent Sealed

30 October 2008 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 16 Sep 2008. Address for service in Australia - Wrays Ground Floor 56 Ord Street West Perth WA 6005

26 March 2009 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 16 Sep 2008

31 March 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003260279-Combination of beta-2 adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders

2003260277-Decoy-Oligonucleotide-inhbition of CD40-expression